ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Biobeat Technologies, Ltd., developer of the first ...
Biobeat Technologies announced it has closed a $50 million Series B equity financing to accelerate the commercialization of its FDA-cleared, cuff-less 24-hour ambulatory blood pressure monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results